ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

House Members Who Voted for Veto

January 3, 1986

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

TGen and George Mason Form Precision Medicine Alliance

May 16, 2014

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Clearinghouse Finds Eight Carcinogens

July 7, 1978

CCOPs ask NCI officials about one-year extensions.

May 20, 2005